World-renowned and internationally acclaimed faculty from MU study infectious diseases such as anthrax, plague and Q-fever at the LIDR under the umbrella of Research Programs. Their research is mainly focused on host-pathogen interactions, immune responses in the host and the development of novel vaccines and therapeutics against disease.
The LIDR also supports the efforts of the Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Disease (MRCE). The MRCE coordinates NIAID funded research on infectious disease research, with emphasis on NIAID Priority Pathogens including those categorized by the CDC as select agents. The MRCE is headquartered at Washington University School of Medicine. MRCE researchers from around the Midwest aiming to develop new vaccines or therapeutics have access to the equipment, facilities and resources of the LIDR. For more information on the MRCE please click here .